drugset / Trial / NCT00988260
Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to find the optimal dose of Org 37462 for Japanese females undergoing controlled ovarian stimulation for in vitro fertilization intracytoplasmic sperm injection (IVF-ICSI).
Timeline
- Start
- 2003-02-03
- Primary completion
- 2004-04-12
- Completion
- 2004-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ganirelix | Protein / enzyme biologic | 0.125 mg | Subcutaneous |
| Subject | Ganirelix | Protein / enzyme biologic | 0.25 mg | Subcutaneous |
| Subject | Ganirelix | Protein / enzyme biologic | 0.5 mg | Subcutaneous |